FDA: Post-Approval Study Finds High Mortality Rate Among Heart Pump Patients
SILVER SPRING, Md. — The Food and Drug Administration on Feb. 5 said it is evaluating interim post-approval study (PAS) results that show that only four out of 23 patients implanted...To view the full article, register now.
Already a subscriber? Click here to view full article